1. Home
  2. INDP vs PED Comparison

INDP vs PED Comparison

Compare INDP & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$1.08

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Logo Pedevco Corp.

PED

Pedevco Corp.

HOLD

Current Price

$12.69

Market Cap

152.8M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDP
PED
Founded
2000
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
171.9M
152.8M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
INDP
PED
Price
$1.08
$12.69
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
103.7K
18.9K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$45,751,000.00
Revenue This Year
N/A
$171.75
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.67
52 Week Low
$0.92
$0.43
52 Week High
$8.57
$18.89

Technical Indicators

Market Signals
Indicator
INDP
PED
Relative Strength Index (RSI) 29.35 58.93
Support Level $0.92 $11.41
Resistance Level $2.95 $13.92
Average True Range (ATR) 0.18 0.75
MACD -0.02 0.24
Stochastic Oscillator 5.83 78.46

Price Performance

Historical Comparison
INDP
PED

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties with a long production history, well-defined geology, and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming, the Powder River Basin (PRB) in Wyoming, and the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin).

Share on Social Networks: